Clinical Trial

Strokectomy in Malignant Cerebral Media Infarction

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 8, 2024 (before its estimated March 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Decompressive hemicraniectomy (DC) is the standard procedure and life saving measure in case of malignant middle cerebral artery (MCA) infarction. However, there have been several studies reporting the neuroinflammatory cascade based on the necrotic tissue as one of the leading cause for the secondary brain damage, wherefore, strokectomy with resection of necrotic tissue has been proposed in some case series as an alternative surgical option. Thus, the aim of this study is to perform a pilot study by including patients with malignant MCA infarction and to check the feasibility of this specific surgical treatment.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06489470
Lead Sponsor University of Rostock
Conditions Stroke, Ischemic
Enrollment 10 participants
Start Date 2024-06-15
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-08